ArticleMikrochimica acta2025
A SERS/bFQICA/Colorimetric triple-mode LFIA method for rapid quantitative detection of meropenem.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Guiding point-of-care therapeutic drug monitoring through structure-toxicity principles.Chemical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Meropenem (MEM), a broad-spectrum carbapenem antibiotic, has a narrow therapeutic window and high interindividual variability. Existing detection methods are often limited by complex operations, long turnaround times, and inadequate sensitivity. To overcome these challenges, this study developed a novel lateral flow immunochromatographic assay (LFIA) platform with synchronous triple-signal output for rapid and accurate MEM detection. A fluorescent membrane sensor was fabricated by integrating Rhodamine 6G (R6G) as a fluorescence donor into a nitrocellulose membrane. Isoniazid (INH, code 064) was selected as the optimal Raman reporter, enabling the synthesis of Raman nanospheres (R-Sphere
Indexed as
Identifiers
41299151What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.